Do Circulating Histones Represent the Missing Link among COVID-19 Infection and Multiorgan Injuries, Microvascular Coagulopathy and Systemic Hyperinflammation?

COVID-19 coagulopathy cytokine storm heparin heparinoids histone inflammation laboratory medicine multiorgan injury neutrophil extracellular trap

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
24 Mar 2022
Historique:
received: 06 02 2022
revised: 21 03 2022
accepted: 23 03 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 13 4 2022
Statut: epublish

Résumé

Several studies shed light on the interplay among inflammation, thrombosis, multi-organ failures and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Increasing levels of both free and/or circulating histones have been associated to coronavirus disease 2019 (COVID-19), enhancing the risk of heart attack and stroke with coagulopathy and systemic hyperinflammation. In this view, by considering both the biological and clinical rationale, circulating histones may be relevant as diagnostic biomarkers for stratifying COVID-19 patients at higher risk for viral sepsis, and as predictive laboratory medicine tool for targeted therapies.

Identifiants

pubmed: 35407410
pii: jcm11071800
doi: 10.3390/jcm11071800
pmc: PMC8999947
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet. 2022 Jan 8;399(10320):118-119
pubmed: 34800425
Int Immunopharmacol. 2022 Apr;105:108542
pubmed: 35063753
Vascul Pharmacol. 2022 Feb;142:106950
pubmed: 34871770
Cardiovasc Res. 2022 Mar 16;118(4):1115-1125
pubmed: 33878183
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028
pubmed: 32286245
Clin Rev Allergy Immunol. 2021 Oct;61(2):194-211
pubmed: 32740860
JAMA Cardiol. 2020 Dec 29;:
pubmed: 33372956
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):988-994
pubmed: 33267662
Thromb Haemost. 2021 Dec;121(12):1637-1649
pubmed: 33984869
Lancet. 2021 Aug 14;398(10300):599-607
pubmed: 34332652
Lancet. 2021 Aug 14;398(10300):561-563
pubmed: 34332651
Thromb Haemost. 2020 Jul;120(7):1004-1024
pubmed: 32473596
Transl Res. 2022 Mar;241:25-40
pubmed: 34780967
Clin Biochem. 2021 Aug;94:12-19
pubmed: 33895124
Clin Chim Acta. 2022 Feb 15;527:33-37
pubmed: 34998858
Antibiotics (Basel). 2021 Nov 13;10(11):
pubmed: 34827332
Curr Opin Hematol. 2022 Jan 1;29(1):53-62
pubmed: 34854835
Clin Chim Acta. 2021 Dec;523:152-162
pubmed: 34537216
Int Immunopharmacol. 2022 Mar;104:108516
pubmed: 35032828
Cells. 2020 Jan 17;9(1):
pubmed: 31963447
Sci Rep. 2022 Jan 12;12(1):640
pubmed: 35022497
Int J Mol Sci. 2021 Apr 17;22(8):
pubmed: 33920656
Blood Adv. 2020 Jun 9;4(11):2404-2408
pubmed: 32484855
J Virol. 2022 Jan 26;96(2):e0106321
pubmed: 34669512
Cells. 2020 Sep 11;9(9):
pubmed: 32932841
Thromb Haemost. 2021 Jul;121(7):849-853
pubmed: 33831961
Front Immunol. 2021 Mar 24;12:650184
pubmed: 33868288
Crit Rev Oncol Hematol. 2021 Dec;168:103529
pubmed: 34800652
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620977702
pubmed: 33539214
Front Mol Biosci. 2021 Mar 18;8:600881
pubmed: 33816549
Exp Ther Med. 2021 Sep;22(3):922
pubmed: 34335883
Front Cell Dev Biol. 2020 Nov 09;8:564169
pubmed: 33240874
Semin Thromb Hemost. 2022 Feb 14;:
pubmed: 35158389
Front Cell Infect Microbiol. 2021 Sep 10;11:694186
pubmed: 34568088
EClinicalMedicine. 2021 Sep;39:101069
pubmed: 34377969
JCI Insight. 2021 Sep 8;6(17):
pubmed: 34264868
EBioMedicine. 2020 Sep;59:102969
pubmed: 32853989
Med Hypotheses. 2021 Jan;146:110470
pubmed: 33412501
Apoptosis. 2021 Apr;26(3-4):152-162
pubmed: 33713214
Cell Death Differ. 2021 Nov;28(11):3125-3139
pubmed: 34031543
Haematologica. 2021 Sep 01;106(9):2493-2498
pubmed: 33832219
PLoS One. 2020 May 29;15(5):e0233644
pubmed: 32469940
Intensive Care Med Exp. 2015 Dec;3(1):36
pubmed: 26715580
Future Cardiol. 2022 Feb;18(2):135-142
pubmed: 34476978
Cells. 2021 Aug 04;10(8):
pubmed: 34440753
Front Pharmacol. 2020 Aug 21;11:1307
pubmed: 32973526
JCI Insight. 2020 Jun 4;5(11):
pubmed: 32329756
Cell Death Dis. 2017 May 25;8(5):e2812
pubmed: 28542146
Biomedicines. 2021 Dec 09;9(12):
pubmed: 34944683
Am J Cardiovasc Dis. 2020 Oct 15;10(4):284-293
pubmed: 33224575
Nat Rev Cardiol. 2022 Jan 13;:
pubmed: 35027697
Circulation. 2020 Nov 10;142(19):1875-1877
pubmed: 32990022
Sci Rep. 2021 Aug 3;11(1):15701
pubmed: 34344929

Auteurs

Daniela Ligi (D)

Unit of Clinical Biochemistry, Department of Biomolecular Sciences-DISB, University of Urbino Carlo Bo, 61029 Urbino, Italy.

Rosanna Maniscalco (R)

Unit of Clinical Biochemistry, Department of Biomolecular Sciences-DISB, University of Urbino Carlo Bo, 61029 Urbino, Italy.

Mario Plebani (M)

Department of Medicine-DIMED, University of Padua, 35128 Padua, Italy.

Giuseppe Lippi (G)

Section of Clinical Biochemistry, University Hospital of Verona, 37134 Verona, Italy.

Ferdinando Mannello (F)

Unit of Clinical Biochemistry, Department of Biomolecular Sciences-DISB, University of Urbino Carlo Bo, 61029 Urbino, Italy.

Classifications MeSH